F Grossi

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

David Liao, F Grossi, Delphine El Mehdi et al. · Ophthalmology · 2019 · 512 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 443 citations · Full text

Medicine, Ophthalmology, Surgery +7

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Jeff Szer, Ilene C. Weitz et al. · New England Journal of Medicine · 2021 · 385 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

On the Ethics of Facial Transplantation Research

Osborne P. Wiggins, John H. Barker, Serge A. Martinez et al. · The American Journal of Bioethics · 2004 · 123 citations

Medicine, Maxillofacial Surgery, Surgery +12

<scp>C3</scp> inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab

Carlos de Castro, F Grossi, Ilene C. Weitz et al. · American Journal of Hematology · 2020 · 98 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10